Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study

Staffan Welin, Seppo W. Langer, Lene Weber Vestermark, +14

Annals of Oncology

Prognostic FactorsGliomaGastrointestinal OncologyMedicineNeuroendocrine Disorder +8

Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid Syndrome

Matthew H. Kulke, Dieter Hörsch, Martyn Caplin, +16

Journal of Clinical Oncology

Treatment with cisplatin and etoposide in patients with neuroendocrine tumors

Marie-Louise H. Fj�llskog, Dan. P. K. Granberg, Staffan Welin, +4

Cancer

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pathology - Diagnosis and Prognostic Stratification

Aurel Perren, Anne Couvelard, Jean‐Yves Scoazec, +12

Neuroendocrinology

GastroenterologyPathologyCancer RegistrationSurgeryPrognostic Stratification +14

Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity

Ulrike Garske‐Román, Mattias Sandström, Katarzyna Fröss Baron, +8

European Journal of Nuclear Medicine and Molecular Imaging

European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes

Johannes Hofland, Massimo Falconi, Emanuel Christ, +11

Journal of Neuroendocrinology

Endocrine OncologyPractical AdvicePancreatic CancerMedicineSurgical Pathology +12

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Biochemical Markers

Kjell Öberg, Anne Couvelard, Gianfranco Delle Fave, +11

Neuroendocrinology

Biochemical MarkersPathologyGliomaTumor BiologyMolecular Pharmacology +18

Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years

Henrik Kindmark, Anders Sundin, Kristina Dunder, +5

Medical Oncology

Retrospective StudyPancreatic CancerPancreatic Fluid CollectionEndocrine Pancreatic TumorsSurgical Pathology +3

Elevated Plasma Chromogranin A Is the First Indication of Recurrence in Radically Operated Midgut Carcinoid Tumors

Staffan Welin, Mats Stridsberg, Janet L. Cunningham, +3

Neuroendocrinology

Association of a Prophylactic Surgical Approach to Stage IV Small Intestinal Neuroendocrine Tumors With Survival

Kosmas Daskalakis, Andreas Karakatsanis, Ola Hessman, +7

JAMA Oncology